Impulsivity also occurs in a range of unconnected categorical conditions that have their common pathway of expression through deficits in executive function (8) . For example, impulsivity as a chronic intermittent condition may well reflect chronic emotional lability, which often is seen as part of chronic dysthymia or borderline personality organization or, less often, reflects a frank mood disorder. Stimulant medication would not be expected to improve emotionally based impulsivity; it would more likely worsen it.
The current Canadian Medical Association guidelines on driving safety include road rage as a subcategory of emotional disorder (9) . The latest edition includes ADHD as a reportable condition if it is uncontrolled and associated with impulsive driving. Impulsive road rage may reflect separate orthogonal variables of cognitive impulsivity and emotional lability, which may require quite different treatment modalities. Further careful research into this nonspecific syndrome, which appears to be presenting with increasing prevalence, seems to have merit, both for public health measures and, possibly, for psychiatric practice.
Reply: Ancient Wine but Still Potent?
Dear Editor: We are grateful for Dr Jerome's contribution to the debate about road rage and its relation to psychiatric distress. He makes the important point that a significant literature exists on psychiatric issues and driving and correctly notes how several different psychiatric problems-such as explosive disorders, attention-deficit hyperactivity disorder (ADHD), and impulsive behaviourmay relate to road rage (for example, 1,2)
Road rage is sometimes portrayed as a new phenomenon, but as Dr Jerome points out, it has a long history. There are literary and historical references to road rage that point to a relation with psychiatric distress. In Sophocles' play Oedipus the King, written about 420 BC, a road rage incident is the ostensible reason for which Oedipus kills his father (3). Oedipus is characterized as impulsive and easily provoked to violence. Sophocles based his Oedipus story on a folk tale, and he may have included the road rage incident because his audience would believe and accept it. The poet Lord Byron was involved in a serious road rage case in 1822 (4). It concerned a dispute over the right-of-way on a road, lasted several hours, and resulted in a serious injury to the supposed perpetrator. Lord Byron was subject to depression at many times during his life, but it is not clear whether this contributed directly to the road rage incident. Byron was also subject to irritation and sudden bouts of violence (4).
We have used the General Health Questionnaire (GHQ) in our own research (5) . The GHQ, a general psychiatric screening instrument for identifying people experiencing psychiatric distress, has proved very useful in survey research (6) . However, it does not assess impulse-control disorders, explosive behaviours, or aggression. Virtually all its items deal with depression, anxiety, and feelings of stress. No questions probe aggression, hostility, or impulse control. Future research in this area would therefore profitably consider these potentially important factors.
Much remains to be done in research on road rage and psychiatric distress. Both victims and perpetrators of road rage should be examined with psychiatric instruments that allow for the identification of ADHD and impulse-control disorders as well as depression and anxiety. As Dr Jerome suggests, mood disorders may underly impulsivity. At present, we also know nothing of how road rage behaviour in young people may relate to various psychiatric problems. It is also important to note that our work does not allow the disentanglement of cause-effect relations; thus we must keep in mind the importance of considering road rage as a cause of such problems as depression and posttraumatic stress disorder (PTSD) (for example, 7).
Available evidence makes it clear that motor vehicle collisions wherein road rage may have played an important role (8) are a major source of injuries and premature death in Canada and also a major source of psychiatric problems such as PTSD (9, 10) . Additional efforts to understand the role of psychiatric problems as both precursors to and results of motor vehicle collisions should be considered as a research priority. We completely agree with Dr Jerome that further understanding of road rage may have important implications for public health and psychiatric practice.
Reginald G Smart, PhD Mark Asbridge, PhD Robert E Mann, PhD Edward Adlaf, PhD Toronto, Ontario
The Effect of Quetiapine on Cannabis Use in 8 Psychosis Patients With Drug Dependency
Dear Editor: Approximately one-half of all patients with schizophrenia abuse or depend on psychoactive substances at some point during their lives (1), but few studies to date have proposed an integrated pharmacologic treatment for this schizophrenia-addiction comorbidity. Because of their strong dopamine D 2 receptor antagonism, conventional antipsychotics such as haloperidol should in theory be the treatment of choice for comorbid schizophrenia and substance abuse. In practice, however, such treatment has not been demonstrated to be consistently effective and has only controlled drug abuse in special cases (2) . A few pilot studies suggest that, among the conventional antipsychotics, flupenthixol may reduce cravings in schizophrenia patients with cocaine addiction (3). To date, the most promising results have been obtained with clozapine, a prototype of the atypical antipsychotics (4). Sharing certain key properties with clozapine (for example, 5-HT 2 -D 2 ratio) (5), quetiapine may also reduce drug cravings in psychosis patients with addictions. A pilot study of 12 patients suffering from bipolar disorder (BD) and cocaine addiction appears to support this hypothesis (6) . To expand on this promising result, we report case histories for 8 psychosis patients whose cannabis use habits significantly improved after treatment with quetiapine.
Case Report
The group of patients (5 men and 3 women) included 4 patients with schizophrenia and 4 with affective BD. All patients had cannabis dependency, and 2 also had a cocaine use disorder, according to DSM-IV criteria. Their mean age was 38.5 years (range 25 to 46 years). Before quetiapine was initiated, they received antipsychotics (5 patients), antidepressants (2 patients), lithium (2 patients), clonazepam (2 patients), and procyclidine (1 patient). All 8 patients were given quetiapine for an average of 5.8 months, at dosages ranging between 100 and 1200 mg daily. Concomitantly, 4 patients received antidepressants, 2 received gabapentin, and 1 was on methadone maintenance treatment. Overall, an average 97.3% reduction in their weekly cannabis use was observed with an average quetiapine dosage of 388 mg daily. When interviewed, patients reported consuming an average of 35.6 g weekly of cannabis (range 18 to 56 g) before quetiapine introduction. After quetiapine treatment, patients reported an average cannabis consumption of 1.1 g weekly.
Like clozapine, quetiapine has proven benefits when compared with conventional antipsychotics (7, 8) . First, clozapine and quetiapine have a beneficial effect on mood. Showing mesolimbic selectivity, these agents do not appear to cause extrapyramidal symptoms. Further, these medications produce little or no neuroleptic-induced dysphoria. Last, it is possible that these atypical antipsychotics (mainly clozapine) alleviate the negative and cognitive symptoms of schizophrenia more than do conventional antipsychotics. To the extent that some patients with schizophrenia may take substances as a form of selfmedication, the clinical data presented here suggest that quetiapine, like clozapine, could form the basis of an integrated pharmacologic treatment for the psychosis-addiction comorbidity. Further controlled research is needed to validate the preliminary data collected to date.
